Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6TSD

Crystal structure of human coxsackievirus A24v in complex with pentavalent inhibitor ME0752

これはPDB形式変換不可エントリーです。
6TSD の概要
エントリーDOI10.2210/pdb6tsd/pdb
関連するPDBエントリー4Q4V 4Q4W 4Q4X 4Q4Y
分子名称Capsid protein VP1, MAGNESIUM ION, Capsid protein VP2, ... (11 entities in total)
機能のキーワードhuman coxsackievirus a24v, starfish-like inhibitor, pentavelent, virus
由来する生物種Coxsackievirus A24
詳細
タンパク質・核酸の鎖数4
化学式量合計99430.40
構造登録者
Zocher, G.,Stehle, T. (登録日: 2019-12-20, 公開日: 2021-07-07, 最終更新日: 2024-01-31)
主引用文献Johansson, E.,Caraballo, R.,Mistry, N.,Zocher, G.,Qian, W.,Andersson, C.D.,Hurdiss, D.L.,Chandra, N.,Thompson, R.,Frangsmyr, L.,Stehle, T.,Arnberg, N.,Elofsson, M.
Pentavalent Sialic Acid Conjugates Block Coxsackievirus A24 Variant and Human Adenovirus Type 37-Viruses That Cause Highly Contagious Eye Infections.
Acs Chem.Biol., 15:2683-2691, 2020
Cited by
PubMed Abstract: Coxsackievirus A24 variant (CVA24v) and human adenovirus 37 (HAdV-37) are leading causative agents of the severe and highly contagious ocular infections acute hemorrhagic conjunctivitis and epidemic keratoconjunctivitis, respectively. Currently, neither vaccines nor antiviral agents are available for treating these diseases, which affect millions of individuals worldwide. CVA24v and HAdV-37 utilize sialic acid as attachment receptors facilitating entry into host cells. Previously, we and others have shown that derivatives based on sialic acid are effective in preventing HAdV-37 binding and infection of cells. Here, we designed and synthesized novel pentavalent sialic acid conjugates and studied their inhibitory effect against CVA24v and HAdV-37 binding and infection of human corneal epithelial cells. The pentavalent conjugates are the first reported inhibitors of CVA24v infection and proved efficient in blocking HAdV-37 binding. Taken together, the pentavalent conjugates presented here form a basis for the development of general inhibitors of these highly contagious ocular pathogens.
PubMed: 32845119
DOI: 10.1021/acschembio.0c00446
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.81 Å)
構造検証レポート
Validation report summary of 6tsd
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon